For R&D use only.

Conivaptan

  • Catalog NO.:A879299
  • CAS No. : 210101-16-9
  • Molecular Formula:C32H26N4O2
  • Molecular Weight: 498.57
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS

Product Details

CAS Number 210101-16-9 Appearance
Catalog Number A879299 MDL Number
Molecular Formula C32H26N4O2 Molecular Weight 498.57
Boiling Point Melting Point
Flash Point Density
Synonyms YM087; Conivaptan;N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements Class
Precautionary Statements Packing Group

Description

Conivaptan (YM 087, brand name Vaprisol) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist). It was approved in 2004 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH), and there is some evidence it may be effective in heart failure. It is marketed by Cumberland Pharmaceuticals, Inc. Conivaptan inhibits two of the three subtypes of the vasopressin receptor (V1a and V2). Effectively, it causes iatrogenic nephrogenic diabetes insipidus. Conivaptan has not been approved by the FDA for the treatment of decompensated congestive heart failure. However, in theory, vasopressin receptor antagonism would be particularly useful in this setting, and an initial study shows that it has some promise.

Related Products

My Tracks: Conivaptan
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Conivaptan
YM087; Conivaptan;N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide